Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

iDesign Aberrometer for the Refractive Treatment of Early Keratoconus

NCT02613780 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT02613780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02613780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
iDesign Aberrometer for the Refractive Treatment of Early Keratoconus
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2016
Completion date
January 31, 2019
Enrollment
24 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

keratoconus